CODS - Journal of Dentistry

Register      Login

VOLUME 7 , ISSUE 1 ( January-June, 2015 ) > List of Articles


Photodynamics in Dentistry - A Review

Vasundhara Shivanna, Rucha Nilegaonkar

Citation Information : Shivanna V, Nilegaonkar R. Photodynamics in Dentistry - A Review. CODS J Dent 2015; 7 (1):13-18.

DOI: 10.5005/cods-7-1-13

License: CC BY-NC-ND 3.0

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2015; The Author(s).


How to cite this article

Shivanna V, Nilegaonkar R. Photodynamics in Dentistry – A Review. CODS J Dent 2015;7:13-18

PDF Share
  1. Photodynamic Therapy: a clinical reality in treatment of cancer. Lancet Oncol 2000; 1: 212-219.
  2. Photodynamic therapy in head and neck cancer. Curr Oncol Rep 2002; 4: 87-96.
  3. Advances in photodynamic therapy for treatment of head and neck cancers. Lasers Surg Med 2006; 38: 349-355.
  4. Clinical PD/PDT in North America: a historical review. Photodiagn Photodyn Ther 2004c; 1: 263-277.
  5. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 42:13-28.
  6. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 2004; 3: 436-450.
  7. Photodynamic therapy for periodontal diseases: state of the art. J Photochem Photobiol B 2005; 79:159-170.
  8. , Akilov, O., and Hasan, T. The potential for photodynamic therapy in the treatment of localized infections. Photodiagn Photodyn Ther 2005; 2:247-262.
  9. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by use of novel drug delivery systems? Adv Drug Deliv Rev 2005; 57:1539-1550.
  10. Photodynamic therapy as an alternative antimicrobial modality for oral infections. J Environ Pathol Toxicol Oncol 2006; 25:487-504.
  11. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother 2006; 57:680-684.
  12. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characteristics of a mucoadhesive patch containing toulidine blue O. J Photochem Photobiol B. 2007; 86:59-69.
  13. Photosensitizing agents – circumventing resistance and breaking down biofilms: a review. Int Biodererior Biodegrad 2004; 53:119-126.
  14. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 2006; 83:27-33.
  15. Low dose Photofrin II photodynamic therapy of psoriasis. J Invest Dermatol 1991;96(Suppl):573-578.
  16. Topical delta-amivolevuliniv acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol 2000; 27:513-518.
  17. Novel transdermal photodynamic therapy using ATX-S10. Na(II) induces apotosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Rheumatol Int 2006; 26:717-725.
  18. Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2006; 90:1152-1156.
  19. Mechanisms in photodynamic therapy: part two – cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2005; 2:1-23.
  20. Photodynamic therapy: unapproved uses, dosages, or indications. Clin Dermatol 2002; 20:571-581.
  21. Photodynamic therapy. Med Laser Appl 2005; 20:37-45.
  22. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int J Cancer 1997; 71:937-942.
  23. Clinical photodynamic therapy of head and neck cancers—a review of applications and outcomes. Photodiagn Photodyn Ther 2005; 2:205-222.
  24. The future of photodynamic therapy in oncology. Future Oncol 2006; 2:53-71.
  25. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 2004; 19:139-149.
  26. Characterization of a simple and homogenous irradiation device based on light-emitting diodes: a possible low-cost supplement to conventional light sources for photodynamic treatment. Med Laser Appl 2006; 21:277-283.
  27. New laser technology and future applications. Med Laser Appl 2006; 21:131-140.
  28. Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens in vitro. Antimicrob Agents Chemother 2000; 44:3364-3367.
  29. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J Photochem Photobiol B 1999; 50:1-7.
  30. Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model. Lasers Surg Med 2003; 33:161-168.
  31. Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue. Lasers Surg Med 2002; 31:86-90.
  32. Antibacterial action of photoactivated disinfection {PAD} used on endodontic bacteria in planktonic suspension and in artificial and human root canals. J Dent 2006; 34:363-371.
  33. An in vitro comparison of the bactericidal efficacy of lethal photosensitization or sodium hypochlorite irrigation on Streptococcus intermedius biofilms in root canals. Int Endod J 2002; 35:268-274.
  34. Association of Enterococcus faecalis with different forms of periradicular diseases. J Endod 2004;30:315-320.
  35. Photodynamic therapy for endodontic disinfection. J Endod 2006; 32:979-984.
  36. Photodynamic inactivation of Enterococcus faecalis in dental root canals in vitro. Lasers Surg Med 2007;39:782-787.
  37. Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med 2007; 39:59-66.
  38. Antimicrobial Effects of Photodynamic Therapy on Patients with Necrotic Pulps and Periapical Lesion. J Endod. 2008 February;34(2):138-142.
  39. Lasers Surg Med. 2007 January;39(1):59-66.
  40. Endodontic photodynamic therapy ex vivo. J Endod. 2011 February;37(2):217-222.
  41. Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin Oral Implants Res 2001; 12:104-108.
  42. Lethal photosensitization, autogenous bone, and e-PTFE membrane for the treatment of peri-implantitis: preliminary results. Int J Oral Maxillofac Implants 2000; 15:374-382.
  43. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob Agents Chemother 2003; 47:932-940.
  44. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol 2005; 76:1100-1105.
  45. Candida biofilms and their role in infection. Trends Microbiol 2003; 11:30-36.
  46. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005; 49:2329-2335.
  47. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93:155-160.
  48. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:67-76.
  49. Oral cancer: complications of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:122-126.
  50. Photodynamic therapy in head and neck cancer. Arch Otolaryngol 1985; 111:351-355.
  51. Photodynamic therapy and the treatment of head and neck cancer. Br J Oral Maxillofac Surg 1988; 26:1-11.
  52. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.